Robert W Cross Selected Research

Robert W Cross Research Topics

Disease

27	Infections 01/2022 - 09/2010
12	COVID-19 03/2022 - 01/2020
9	Vesicular Stomatitis 01/2022 - 12/2013
7	Ebola Hemorrhagic Fever 01/2022 - 10/2016
6	Lassa Fever (Fever, Lassa) 01/2020 - 01/2016
5	Virus Diseases (Viral Diseases) 01/2022 - 11/2018
3	Marburg Virus Disease 01/2022 - 10/2015
3	Fever (Fevers) 01/2021 - 10/2016
2	Crimean Hemorrhagic Fever 01/2021 - 01/2019
2	Henipavirus Infections 11/2020 - 12/2013
2	Convalescence 08/2020 - 01/2020
2	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2020 - 01/2020
2	Viremia 01/2020 - 10/2015
1	Dermatitis 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Vascular Skin Diseases 01/2022
1	American Hemorrhagic Fever (Bolivian Hemorrhagic Fever) 01/2021
1	Disease Progression 01/2021
1	Cytokine Release Syndrome 01/2020
1	Inflammation (Inflammations) 01/2020
1	Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever) 01/2019
1	Lymphopenia (Lymphocytopenia) 01/2017
1	Disseminated Intravascular Coagulation 10/2015
1	Epidemic Louse-Borne Typhus (Typhus) 02/2015
1	Nervous System Diseases (Neurological Disorders) 12/2013
1	Bacterial Infections (Bacterial Infection) 05/2011
1	Human Influenza (Influenza) 05/2011

Drug/Important Bio-Agent (IBA)

18	VaccinesIBA 01/2022 - 05/2011
13	Monoclonal AntibodiesIBA 03/2022 - 01/2016
12	Glycoproteins (Glycoprotein)IBA 01/2022 - 12/2013
8	AntibodiesIBA 01/2022 - 01/2016
8	AntigensIBA 12/2021 - 12/2013
5	CytokinesIBA 01/2020 - 05/2011
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2011
3	Neutralizing AntibodiesIBA 12/2021 - 10/2020
3	Antiviral Agents (Antivirals)IBA 11/2020 - 01/2019
2	EpitopesIBA 03/2022 - 11/2020
2	remdesivirIBA 01/2022 - 01/2021
2	bamlanivimabIBA 12/2021 - 10/2020
2	Protein CIBA 11/2020 - 10/2015
2	CollagenIBA 08/2020 - 01/2020
2	Immunoglobulin M (IgM)IBA 01/2020 - 02/2015
2	Immunoglobulin G (IgG)IBA 01/2020 - 02/2015
2	Indicators and Reagents (Reagents)IBA 11/2018 - 05/2011
2	ChemokinesIBA 01/2017 - 05/2011
2	EnzymesIBA 10/2015 - 02/2015
1	Plasminogen Activator Inhibitor 1IBA 01/2021
1	Combined VaccinesIBA 01/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021
1	Subunit VaccinesIBA 01/2021
1	SolutionsIBA 01/2021
1	Hormones (Hormone)IBA 01/2020
1	HLA-DR Antigens (HLA-DR)IBA 01/2020
1	Recombinant ProteinsIBA 01/2020
1	ZincIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	NucleoproteinsIBA 01/2020
1	Polysaccharides (Glycans)IBA 11/2018
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 11/2018
1	Small Interfering RNA (siRNA)IBA 12/2017
1	InterferonsIBA 01/2017
1	Fibrinogen (Factor I)FDA Link 10/2015
1	FibrinIBA 10/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2015
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 10/2015
1	ImmunosorbentsIBA 02/2015
1	Ribavirin (Virazole)FDA LinkGeneric 03/2014
1	attachment protein GIBA 12/2013
1	GTP-Binding Proteins (G-Protein)IBA 12/2013
1	Blood Group Antigens (Blood Groups)IBA 09/2010

Therapy/Procedure

10	Therapeutics 01/2022 - 05/2011